Skip to content
2000
Volume 5, Issue 3
  • ISSN: 1570-193X
  • E-ISSN: 1875-6298

Abstract

The recent advances of PET using biomolecules, such as peptides, monoclonal antibodies, oligonucleotides, and glycoproteins will be described. So far, PET of biomolecules has been used mainly for diagnosis of cancers. The biomolecules have been conjugated with DOTA ligand, labeled with radiometals as the β+ emitter, and targeted to specific tumors, where they have enabled visualization of even small metastatic lesions, due to the high sensitivity of the PET scanners.

Loading

Article metrics loading...

/content/journals/mroc/10.2174/157019308785161684
2008-08-01
2025-09-21
Loading full text...

Full text loading...

/content/journals/mroc/10.2174/157019308785161684
Loading

  • Article Type:
    Research Article
Keyword(s): diagnosis; DOTA; Positron emission tomography (PET); tumor; β+ emitter, biomolecule
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test